Evidence map›Paper›PMID 34724916›Full record

ArticleBMC nephrology2021

Risk factors associated with albuminuria in Rwanda: results from a STEPS survey.

Candide Tran Ngoc, Prebo Barango, Roger Harrison, Andrew Jones, Steven Velabo Shongwe, Albert Tuyishime, François Uwinkindi, Hongyi Xu, Stephanie Shoop-Worrall

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Candide Tran NgocWorld Health Organization, Country Office for Rwanda, Kigali, Rwanda. tranngocc@who.int.
Prebo BarangoWorld Health Organization, Inter Country Support Team, Eastern and Southern Africa, Harare, Zimbabwe.
Roger HarrisonDivision of Population Health, Health Services Research & Primary Care, The University of Manchester, Manchester, UK.
Andrew JonesDivision of Population Health, Health Services Research & Primary Care, The University of Manchester, Manchester, UK.
Steven Velabo ShongweWorld Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
Albert TuyishimeRwanda Biomedical Center, Kigali, Rwanda.
François UwinkindiRwanda Biomedical Center, Kigali, Rwanda.
Hongyi XuWorld Health Organization, Headquarters, Geneva, Switzerland.
Stephanie Shoop-WorrallDivision of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, UK.
Manchester Academic Health Science Centre · GBRwanda Biomedical Center · RWUniversity of Manchester · GBWorld Health Organization · CHWorld Health Organization Regional Office for Africa · CGWorld Health Organization - Zimbabwe · ZW

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundNon-communicable diseases (NCDs) are a growing burden which affects every part of the world, including developing countries. Chronic kidney disease (CKD) has varied etiology which can result from or complicate other NCDs such as diabetes and cardiovascular diseases. The growing prevalence of NCDs coupled with the increasing age in most developing countries, has seen a marked increase of CKD in these settings. CKD has been described as "the most neglected NCD" and greatly affects the quality of life of patients. It also places a huge economic burden on societies. However, few epidemiological data exist, particularly in sub-Saharan Africa. Assessment of the prevalence of albuminuria as a marker of kidney damage and CKD progression and its main risk factors was thus needed in Rwanda.

methodsThis study analyzed data collected during the first STEPwise approach to NCD risk factor Surveillance (STEPS) survey in Rwanda, conducted from 2012 to 2013, to assess the prevalence of albuminuria. A multistage cluster sampling allowed to select a representative sample of the general population. Furthermore, descriptive, as well as univariable analyses and multiple logistic regression were performed to respond to the research question.

resultsThis survey brought a representative sample of 6,998 participants, among which 4,384 (62.65%) were female. Median age was 33 years (interquartile range, IQR 26-44), and over three quarters (78.45%) lived in rural areas. The albuminuria prevalence was 105.9 per 1,000 population. Overall, semi-urban and urban residency were associated with lower odds of CKD (odds ratio, OR 0.36, CI 0.23-0.56, p<0.001 and OR 0.34, CI 0.23-0.50, p<0.001, respectively) than rural status. Being married or living with a partner had higher odds (OR 1.44 (CI 1.03-2.02, p=0.031) and OR 1.62 (CI 1.06-2.48, p=0.026), respectively) of CKD than being single. Odds of positive albuminuria were also greater among participants living with human immunodeficiency virus (HIV) (OR 1.64, CI 1.09- 2.47, p=0.018). Gender, age group, smoking status and vegetable consumption, body mass index (BMI) and hypertension were not associated with albuminuria.

conclusionThe albuminuria prevalence was estimated at 105.9 per 1,000 in Rwanda. Rural residence, partnered status and HIV positivity were identified as main risk factors for albuminuria. Increased early screening of albuminuria to prevent CKD among high-risk groups, especially HIV patients, is therefore recommended.

Indexed as

AdolescentAdultAlbuminuriaCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRenal Insufficiency, ChronicRisk FactorsRwandaSelf ReportYoung Adult

Identifiers

PMID34724916
PMCPMC8561895
OpenAlexW3210599453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.